Effect of Vitamin C on Triglyceride Levels in Critical Care Patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the impact of vitamin C administration on triglyceride levels in critically ill patients. It aims to determine whether intravenous vitamin C can effectively lower triglyceride levels in patients admitted to the intensive care unit, particularly those with conditions that often lead to hypertriglyceridemia. The study will compare patients receiving vitamin C treatment to a control group not receiving the treatment, focusing on various factors such as age and duration of vitamin C administration.

Why it matters

Who can join: the full rules

Inclusion Criteria: patients aged 18-99 who were admitted to the general intensive care unit from January 2017 to December 2023, and who were treated with intravenous vitamin C. The control group will include patients with the same characteristics who were not treated with vitamin C.

Exclusion criteria: patients who did not meet the above conditions or for whom data were missing.

\-

\-

Where it's running

• Meir Medical Center
  Kfar Saba, Israel Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Ion775 for high triglyceride levels: safety, tolerability, and how well it works

  A drug called ION775 is being tested to see if it can safely lower fasting triglycerides in adults with hypertriglyceridemia or severe hypertriglyceridemia who are already on standard lipid medicines.

  Recruiting at 17 sites Phase 2 Ionis Pharmaceuticals, Inc. · Lincoln, California and 17 other locations · NCT07604974

• Russian registry for people with very high triglycerides

  This registry collects health and genetic information from people in Russia who have very high triglycerides (≥10 mmol/L) to see what their causes, care, and outcomes look like.

  Recruiting at 6 sites Russian Cardiology Research and Production Center · Astrakhan and 5 other locations · NCT07508930

• CTX310 for refractory high triglycerides or LDL cholesterol

  This trial will test whether a single IV dose of CTX310 is safe and tolerated in adults whose high triglycerides or LDL cholesterol have not responded to available treatments.

  Recruiting at 16 sites Phase 1 CRISPR Therapeutics · Hialeah, Florida and 16 other locations · NCT07491172

• High-speed centrifugation to enable anti-Xa testing on lipemic (fatty) blood samples

  This will test whether spinning fatty (lipemic) blood samples very fast helps the lab get accurate anti-Xa measurements for adults on anti-Xa anticoagulant medications.

  Recruiting University Hospital, Strasbourg, France · Strasbourg · NCT07200674

• MAR001 for adults with high triglycerides and remnant cholesterol

  This trial will try the drug MAR001 to lower post-meal triglycerides and remnant cholesterol in adults with elevated triglyceride levels.

  Recruiting Phase 2 Marea Therapeutics · Chula Vista, California · NCT07199309

• JMT202 injections for adults with high triglycerides

  This will test whether repeated subcutaneous injections of JMT202 are safe and well tolerated in Chinese adults with high triglyceride levels.

  Recruiting Phase 1/2 Shanghai JMT-Bio Inc. · Beijing, Beijing Municipality · NCT07140809

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.